Psyence Biomedical Ltd. Common Shares (PBM) — Cash Flow-to-Debt Ratio
Psyence Biomedical Ltd. Common Shares (PBM) has a Cash Flow-to-Debt Ratio of -0.05x as of December 2023, meaning its operating cash flow of $-662.00 could theoretically repay 0% of its total liabilities ($12.10K) in one year. See PBM current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Psyence Biomedical Ltd. Common Shares Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Psyence Biomedical Ltd. Common Shares across 4 annual periods. Also explore PBM net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Psyence Biomedical Ltd. Common Shares (2022–2025)
Year-by-year debt coverage analysis for Psyence Biomedical Ltd. Common Shares. For market capitalisation and broader financial context, see PBM stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.28x | $-3.73 Million | $594.37K | ▼ -2482.0% |
| 2024 | -0.24x | $-2.95 Million | $12.10 Million | ▼ -568.3% |
| 2023 | -0.04x | $-519.60K | $14.27 Million | ▲ +57.3% |
| 2022 | -0.09x | $-1.40 Million | $16.38 Million | — |